GR870917B - Novel mehthod of preparing toxoid - Google Patents

Novel mehthod of preparing toxoid

Info

Publication number
GR870917B
GR870917B GR870917A GR870100917A GR870917B GR 870917 B GR870917 B GR 870917B GR 870917 A GR870917 A GR 870917A GR 870100917 A GR870100917 A GR 870100917A GR 870917 B GR870917 B GR 870917B
Authority
GR
Greece
Prior art keywords
mehthod
novel
toxoid
preparing
preparing toxoid
Prior art date
Application number
GR870917A
Other languages
English (en)
Inventor
Ronald D Sekura
Original Assignee
Ronald D Sekura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ronald D Sekura filed Critical Ronald D Sekura
Publication of GR870917B publication Critical patent/GR870917B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/20—Rubella virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR870917A 1986-06-16 1987-06-12 Novel mehthod of preparing toxoid GR870917B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,637 US4762710A (en) 1986-06-16 1986-06-16 Novel method of preparing toxoid by oxidation and metal ions

Publications (1)

Publication Number Publication Date
GR870917B true GR870917B (en) 1987-10-15

Family

ID=25364220

Family Applications (1)

Application Number Title Priority Date Filing Date
GR870917A GR870917B (en) 1986-06-16 1987-06-12 Novel mehthod of preparing toxoid

Country Status (14)

Country Link
US (1) US4762710A (el)
EP (1) EP0269729B1 (el)
JP (1) JP2617500B2 (el)
KR (1) KR960010834B1 (el)
CN (1) CN1033003C (el)
AT (1) ATE87486T1 (el)
AU (1) AU604497B2 (el)
CA (1) CA1302883C (el)
DE (1) DE3785157T2 (el)
ES (1) ES2006763A6 (el)
GR (1) GR870917B (el)
IL (1) IL82825A (el)
WO (1) WO1987007507A1 (el)
ZA (1) ZA874064B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165927A (en) * 1986-08-01 1992-11-24 University Of Southern California Composition with modified pertussis toxin
US5032398A (en) * 1986-08-01 1991-07-16 Kaslow Harvey R Selective modification of the catalytic subunit of pertussis toxin
SE455946B (sv) * 1986-10-20 1988-08-22 Trion Forskning & Utveckling Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner
JP2849632B2 (ja) * 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
AU631351B2 (en) * 1988-04-20 1992-11-26 Massachusetts Health Research Institute, Inc. (Mhri) Pertussis toxoid vaccine
AP8900132A0 (en) * 1988-07-22 1991-01-14 Smithkline Biolog Bordetella pertussis vaccine
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
EP0485652A1 (de) * 1990-11-14 1992-05-20 Theurer, Karl E., Prof.Dr.med. Verfahren zur Herstellung von Impfvaccinen gegen Krankheitserreger
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
AU2003239773A1 (en) * 2002-06-28 2004-01-19 Novozymes A/S Preparation of vaccines
EP1942932B1 (en) * 2005-08-08 2013-05-08 Oregon Health and Science University Inactivating pathogens with hydrogen peroxide for vaccine production
WO2021001540A1 (en) 2019-07-04 2021-01-07 Proxi Biotech Aps Detoxification of proteins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097141A (en) * 1959-02-26 1963-07-09 Kidwell Elizabeth N Wilcox Immunological method
US3529057A (en) * 1964-08-14 1970-09-15 Takeda Chemical Industries Ltd Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4058599A (en) * 1973-02-24 1977-11-15 Bayer Aktiengesellschaft Ethyleneimine inactivated organisms
DE2340911A1 (de) * 1973-08-13 1975-05-07 Behringwerke Ag Tetanus-antigen und verfahren zu seiner herstellung
CA1083508A (fr) * 1975-11-13 1980-08-12 Jacques Grange Supports porteurs de chaines laterales, procedes d'obtention de ces supports, procedes de fixation de composes organiques comportant un residu glucidique sur lesdits supports, produits et reactifs resultant de ladite fixation chimique
US4172126A (en) * 1976-11-08 1979-10-23 Sankyo Company Limited Method for the inactivation of microbial toxins and attenuation of vaccines
US4256732A (en) * 1978-08-15 1981-03-17 Research Corporation Modified grass pollen antigens
US4314993A (en) * 1980-04-04 1982-02-09 Smithkline-Rit Immunogenic E. coli ST enterotoxin derivatives and compositions containing them
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
CH664497A5 (de) * 1984-08-31 1988-03-15 Solco Basel Ag Vakzine zur behandlung der harnwegsinfektionen.

Also Published As

Publication number Publication date
WO1987007507A1 (en) 1987-12-17
US4762710A (en) 1988-08-09
EP0269729B1 (en) 1993-03-31
CA1302883C (en) 1992-06-09
EP0269729A1 (en) 1988-06-08
CN87104279A (zh) 1988-01-20
AU604497B2 (en) 1990-12-20
AU7804787A (en) 1988-01-11
DE3785157D1 (de) 1993-05-06
KR960010834B1 (ko) 1996-08-09
KR880701109A (ko) 1988-07-25
DE3785157T2 (de) 1993-11-04
EP0269729A4 (en) 1988-10-06
IL82825A (en) 1992-05-25
JP2617500B2 (ja) 1997-06-04
ES2006763A6 (es) 1989-05-16
ATE87486T1 (de) 1993-04-15
IL82825A0 (en) 1987-12-20
ZA874064B (en) 1988-04-27
CN1033003C (zh) 1996-10-16
JPH01500354A (ja) 1989-02-09

Similar Documents

Publication Publication Date Title
IL82825A0 (en) Preparation of toxoid
EP0242205A3 (en) Vaccine formulation
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
EP0162639A3 (en) Antigenic preparations and isolation of such preparations
ES499112A0 (es) Metodo de producir toxoide de pertussis
HUT35521A (en) Process for preparing a pharmaceutical composition containing a purified, detixicated endotoxine and a pyridine soluble extract of a microorganism
PT91953A (pt) Processo para a preparacao de solucoes de antigenes contendo hidroxido de zinco ou hidroxido de ferro como agente auxiliar
IL63924A0 (en) Preparation of 4'-deoxy-daunorubicin and 4'-deoxy-doxorubicin
EP0202947A3 (en) Vaccine production
CA2044721A1 (en) Preparation and use of enzyme-detergent extracted streptococcus zooepidemicus vaccine
CY1935A (en) Novel vaccine and method therefor
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
GB8523097D0 (en) Producing storable camomile extracts
DE3660204D1 (en) Process for the preparation of dichlorotrifluoroethoxy and ethylthioaromatic derivatives
CA2004206A1 (en) Method for preparing pertussis toxin toxoid
EP0338566A3 (en) Pertussis toxoid vaccine
ZA913920B (en) Therapeutic compound
FI102973B1 (fi) Menetelmä 17-oksosteroidien valmistamiseksi